slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 32,221-32,250
Pages 1,418
Rows per page 30
Beat
32,221-32,250 of 42,534
16
The slide outlines the randomization, treatment arms, timeline, patient population criteria, and primary/secondary endpoints.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
17
Uses a combination of an additive equation for the value prop and a chevron-based timeline for the life cycle management.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
26
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
27
The slide uses a three-column icon-based layout to summarize key IP milestones.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
28
The slide uses a grid layout to display headshots and names for the executive team, and a list format for the board of directors with associated company logos.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
29
The slide combines a financial summary with a timeline of milestones and a value proposition for their lead asset.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
21
MaxCyte | Investor Presentation Deck | 21 slidesMaxCyte | Investor Presentation Deck | 21 slides · MaxCyte
Pitch deck Investor relations Beat · The AskLoop · Why Now1 hit
10
Morgan Stanley | Investor Presentation Deck | 13 slidesMorgan Stanley | Investor Presentation Deck | 13 slides · Morgan Stanley
Conference presentation Investor relations Beat · New Bliss1 hit
11
Includes reconciliation table for Net Revenues and Pre-Tax Profit adjustments.Morgan Stanley | Investor Presentation Deck | 13 slides · Morgan Stanley
Conference presentation Investor relations Beat · New Bliss1 hit
12
Standard financial disclosure page for Morgan Stanley investor presentation.Morgan Stanley | Investor Presentation Deck | 13 slides · Morgan Stanley
Conference presentation Investor relations Beat · New Bliss1 hit
13
Morgan Stanley | Investor Presentation Deck | 13 slidesMorgan Stanley | Investor Presentation Deck | 13 slides · Morgan Stanley
Conference presentation Investor relations Beat · New Bliss1 hit
06
The slide uses a biological mechanism-of-action illustration to show how the drug components interact with specific cellular stressors.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a combination of a biological mechanism diagram and a pharmacokinetic line chart to prove efficacy.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
08
Includes a process diagram for iPSC generation and two charts: a survival curve and a hazard ratio bar chart.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
09
The chart demonstrates that PrimeC aligns the peak concentrations of two different drugs, which is the core value proposition of their formulation technology.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
10
Study identifier NST002, 15 patients, open-label, intermediate formulation.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
11
Includes details on screen failures and co-treatment with Riluzole.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
12
Uses numbered icons for primary/secondary and a lightbulb icon for exploratory.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
13
Includes a footnote citation for the methodology definitions.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
14
NeuroSense Therapeutics | Investor Presentation Deck | 33 slidesNeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
15
The slide shows baseline characteristics for a clinical trial, confirming that the treatment and placebo groups are well-matched.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
16
The table displays percentages for various categories of adverse events (AEs) and treatment-emergent adverse events (TEAEs).NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
17
The slide highlights a statistically significant 37.4% reduction in disease progression for the Per Protocol population, while noting a 29% reduction (p=0.12) for the ITT population in the footer.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
07
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
08
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
09
Oscar Health | Investor Conference Presentation Deck | 9 slidesOscar Health | Investor Conference Presentation Deck | 9 slides · Oscar Health
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
04
Talkspace | Investor Conference Presentation Deck | 13 slidesTalkspace | Investor Conference Presentation Deck | 13 slides · Talkspace
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Includes screenshots of a research paper and a press release as evidence.Talkspace | Investor Conference Presentation Deck | 13 slides · Talkspace
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Quick Win Big Bet1 hit
10
The slide uses a grid of cards to present quantitative improvements in EBITDA, Opex, network growth, covered lives, and session volume, alongside a qualitative milestone.Talkspace | Investor Conference Presentation Deck | 13 slides · Talkspace
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Quick Win Big Bet1 hit
11
Talkspace | Investor Conference Presentation Deck | 13 slidesTalkspace | Investor Conference Presentation Deck | 13 slides · Talkspace
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Quick Win Big Bet1 hit